| Jennifer Renee Palmer, MD | |
|
1774 Mcfarland Blvd N, Tuscaloosa, AL 35406-2136 | |
| (205) 759-2920 | |
| (205) 759-1344 |
| Full Name | Jennifer Renee Palmer |
|---|---|
| Gender | Female |
| Speciality | Gastroenterology |
| Experience | 15 Years |
| Location | 1774 Mcfarland Blvd N, Tuscaloosa, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861626251 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 34253 (Alabama) | Primary |
| 207R00000X | Internal Medicine | MD.204568 (Louisiana) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| D C H Regional Medical Center | Tuscaloosa, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| G I Associates Of West Alabama Pc | 4082654314 | 15 |
News Archive
Kyle Goerl, the medical director of Kansas State University's Lafene Health Center, is part of a collaborative team that is providing research-based guidance during the COVID-19 pandemic.
South Africa's Department of Health last Thursday announced that it has allocated about $5 million this year to help achieve the goal of distributing three million female condoms in 2006, the SAPA/iafrica.com reports.
Salix Pharmaceuticals, Ltd. today announced that the Company has submitted an efficacy supplement to NDA 21-361 for XIFAXAN® (rifaximin) 550 mg tablets for the proposed indication of treatment of non-constipation irritable bowel syndrome (Non-C IBS) and IBS-related bloating.
Now, a new preprint research paper posted to the bioRxiv server reports the development of a modified mouse model that allows productive SARS-CoV-2 infection of the mouse lungs, as well as the exploration of type I and III interferon responses in this condition.
IRIN reports on "the improved availability of essential medicines in Zimbabwe's public health sector" as a result of "a multi-donor program started in 2008 through collaboration between the government, the U.N. Children's Fund (UNICEF) Zimbabwe, the European Union (E.U.), the U.K., Australia, Canada and Ireland."
› Verified 4 days ago
| Entity Name | North River Surgical Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1215926993 PECOS PAC ID: 9638137029 Enrollment ID: O20050103000231 |
News Archive
Kyle Goerl, the medical director of Kansas State University's Lafene Health Center, is part of a collaborative team that is providing research-based guidance during the COVID-19 pandemic.
South Africa's Department of Health last Thursday announced that it has allocated about $5 million this year to help achieve the goal of distributing three million female condoms in 2006, the SAPA/iafrica.com reports.
Salix Pharmaceuticals, Ltd. today announced that the Company has submitted an efficacy supplement to NDA 21-361 for XIFAXAN® (rifaximin) 550 mg tablets for the proposed indication of treatment of non-constipation irritable bowel syndrome (Non-C IBS) and IBS-related bloating.
Now, a new preprint research paper posted to the bioRxiv server reports the development of a modified mouse model that allows productive SARS-CoV-2 infection of the mouse lungs, as well as the exploration of type I and III interferon responses in this condition.
IRIN reports on "the improved availability of essential medicines in Zimbabwe's public health sector" as a result of "a multi-donor program started in 2008 through collaboration between the government, the U.N. Children's Fund (UNICEF) Zimbabwe, the European Union (E.U.), the U.K., Australia, Canada and Ireland."
› Verified 4 days ago
| Entity Name | G I Associates Of West Alabama Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316985757 PECOS PAC ID: 4082654314 Enrollment ID: O20050505001172 |
News Archive
Kyle Goerl, the medical director of Kansas State University's Lafene Health Center, is part of a collaborative team that is providing research-based guidance during the COVID-19 pandemic.
South Africa's Department of Health last Thursday announced that it has allocated about $5 million this year to help achieve the goal of distributing three million female condoms in 2006, the SAPA/iafrica.com reports.
Salix Pharmaceuticals, Ltd. today announced that the Company has submitted an efficacy supplement to NDA 21-361 for XIFAXAN® (rifaximin) 550 mg tablets for the proposed indication of treatment of non-constipation irritable bowel syndrome (Non-C IBS) and IBS-related bloating.
Now, a new preprint research paper posted to the bioRxiv server reports the development of a modified mouse model that allows productive SARS-CoV-2 infection of the mouse lungs, as well as the exploration of type I and III interferon responses in this condition.
IRIN reports on "the improved availability of essential medicines in Zimbabwe's public health sector" as a result of "a multi-donor program started in 2008 through collaboration between the government, the U.N. Children's Fund (UNICEF) Zimbabwe, the European Union (E.U.), the U.K., Australia, Canada and Ireland."
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Renee Palmer, MD 1774 Mcfarland Blvd N, Tuscaloosa, AL 35406-2136 Ph: (205) 759-2920 | Jennifer Renee Palmer, MD 1774 Mcfarland Blvd N, Tuscaloosa, AL 35406-2136 Ph: (205) 759-2920 |
News Archive
Kyle Goerl, the medical director of Kansas State University's Lafene Health Center, is part of a collaborative team that is providing research-based guidance during the COVID-19 pandemic.
South Africa's Department of Health last Thursday announced that it has allocated about $5 million this year to help achieve the goal of distributing three million female condoms in 2006, the SAPA/iafrica.com reports.
Salix Pharmaceuticals, Ltd. today announced that the Company has submitted an efficacy supplement to NDA 21-361 for XIFAXAN® (rifaximin) 550 mg tablets for the proposed indication of treatment of non-constipation irritable bowel syndrome (Non-C IBS) and IBS-related bloating.
Now, a new preprint research paper posted to the bioRxiv server reports the development of a modified mouse model that allows productive SARS-CoV-2 infection of the mouse lungs, as well as the exploration of type I and III interferon responses in this condition.
IRIN reports on "the improved availability of essential medicines in Zimbabwe's public health sector" as a result of "a multi-donor program started in 2008 through collaboration between the government, the U.N. Children's Fund (UNICEF) Zimbabwe, the European Union (E.U.), the U.K., Australia, Canada and Ireland."
› Verified 4 days ago
Robert Pieroni, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 850 5th Ave E, Tuscaloosa, AL 35401 Phone: 205-348-1770 Fax: 205-348-5353 | |
Dr. Mark Bruce Nissenbaum, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 3701 Loop Rd, Va Medical Center (679/11), Tuscaloosa, AL 35404 Phone: 205-554-2000 Fax: 205-554-2034 | |
Dr. Kyathanahally M. Dinesh Chandra, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 701 University Blvd E, Suite 711, Tuscaloosa, AL 35401 Phone: 205-345-2255 | |
John Warren, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1100 Ruby Tyler Pkwy, Tuscaloosa, AL 35404 Phone: 205-759-2582 Fax: 205-759-2985 | |
Dr. Neil Kirit Shah, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 850 Peter Bryce Blvd, Tuscaloosa, AL 35401 Phone: 205-348-1770 Fax: 205-348-5145 | |
Bassam Mushannen, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1060 Fairfax Park, Ste B, Tuscaloosa, AL 35406 Phone: 205-758-6471 Fax: 205-758-6472 | |
Michael Shortall, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 3701 Loop Rd, Tuscaloosa, AL 35404 Phone: 205-554-2000 Fax: 205-554-2824 |